Company intelligence / Profile preview

Chuanglan Biotech

Suzhou, Jiangsu Province, Chinachictr.org.cn ↗

Ownership: Private
Development stage: Commercial

Overview

Chuanglan Biotech focuses on applying genetic testing technologies to the medical clinical field, developing corresponding diagnostic reagents and related products. There is no public information about drug development or therapeutic clinical trials; their main business appears to be commercialized genetic diagnostics for healthcare applications.

Therapeutic areas: Other
Modalities: Diagnostic reagentGenetic testing technology
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on Chuanglan Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chuanglan Biotech.

Explore the full profile